Adenovirus-mediated delivery of human kallistatin gene reduces blood pressure of spontaneously hypertensive rats

Human Gene Therapy

Volumn 8, Issue 3, 1997, Pages 341-347

  Chen, Li Mei ^a   Chao, Lee ^a   Chao, Julie ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; COMPLEMENTARY DNA; KALLIKREIN; KALLISTATIN; MESSENGER RNA; RECOMBINANT PROTEIN; SERINE PROTEINASE INHIBITOR; UNCLASSIFIED DRUG;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; BLOOD PRESSURE; COMPLEX FORMATION; CONTROLLED STUDY; EMBRYO; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE; GENE TARGETING; HUMAN; HUMAN TISSUE; HYPERTENSION; KIDNEY; LIVER; LONG TERMINAL REPEAT; LUNG; MALE; NONHUMAN; PORTAL VEIN; PROMOTER REGION; RAT; ROUS SARCOMA ONCOVIRUS; SPLEEN; SPONTANEOUSLY HYPERTENSIVE RAT; VASODILATATION;

ADENOVIRIDAE; ANIMALIA; MUS MUSCULUS; ONCOVIRINAE; RICE STRIPE VIRUS; ROUS SARCOMA VIRUS;

EID: 0030798507     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1997.8.3-341     Document Type: Article

References (21)

1. CHAI, X.K., CHEN, L-M., CHAO, J., and CHAO, L. (1993). Kallistatin: A novel human serine proteinase inhibitor. Molecular cloning, tissue distribution, and expression in Escherichia coli. J. Biol. Chem. 268, 24498-24505.
2. CHAI, X.K., WARD, D.C., CHAO, J., and CHAO, L. (1994). Molecular cloning, sequence analysis, and chromosomal localization of the human protease inhibitor 4 (kallistatin) gene (PI4). Genomics 23, 370-378.
3. CHAO, J., and CHAO, L. (1988). A major difference of kallikrein-binding protein in spontaneously hypertensive versus normotensive rats. J. Hypertens. 6, 551-557.
4. CHAO, J., and CHAO, L. (1995). Biochemistry, regulation and potential function of kallistatin. Biol. Chem. Hoppe-Seyler 376, 705-713.
5. CHAO, J., CHAI, K.X., CHEN, L-M., XIONG, W., CHAO, S., WOODLEY-MILLER, C., WANG, L., LU, H.S., and CHAO, L. (1990). Tissue kallikrein-binding protein is a serpin. I. Purification, characterization, and distribution in normotensive and spontaneously hypertensive rats. J. Biol. Chem. 265, 16394-16401.
6. CHAO, J., SCHMAIER, A., CHEN, L-M., YANG, R., and CHAO, L. (1996a). Kallistatin, a novel human tissue kallikrein inhibitor: levels in bodily fluids, blood cells and tissues in health and disease. J. Lab. Clin. Med. 127, 612-620.
7. CHAO, J., JIN, L., CHEN, L-M., CHEN, V.C., and CHAO, L. (1996b). Systemic and portal vein delivery of human kallikrein gene reduces blood pressure in hypertensive rats. Hum. Gene Ther. 7, 901-911.
8. CHAO, J., STALLONE, J.N., LIANG, Y-M., CHEN, L-M., and CHAO, L. (1996c). Kallistatin is a potent new vasodilator. (manuscript in preparation).
9. CHEN, L-M., SONG, Q., CHAO, L., and CHAO, J. (1995). Cellular localization of tissue kallikrein and kallistatin mRNAs in human kidney. Kidney Int. 48, 690-697.
10. CHEN, L-M., MA, J-X., LIANG, Y-M., CHAO, L., and CHAO, J. (1996), Tissue kallikrein-binding protein reduces blood pressure in transgenic mice. J. Biol. Chem. 271, 27590-27594.
11. CHIRGWIN, J.M., PRZYBYLA, A.E., MACDONALD, R.J., and RUTTER, W.J. (1979). Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18, 5294-5299.
12. HORWITZ, M.S. (1988). Virology, 2nd ed. B.N. Fields and D.M. Knipe, eds. pp. 1679-1721.
13. IYER, S.N., LU, D., KATOVICH, M.J., and RAIZADA, M.K. (1996). Chronic control of high blood pressure in the spontaneously hypertensive rat by delivery of angiotensin type 1 receptor antisense. Proc. Natl. Acad. Sci. USA 93, 9960-9965.
14. LIN, K.F., CHAO, L., and CHAO, J. (1995). Human atrial natriuretic peptide gene delivery reduces blood pressure in hypertensive rats. Hypertension 26, 847-853.
15. LINDPAINTNER, K., CHAI, K.X., KREUTZ, R., HUBNER, N., KAHLING, M., GANTEN, D., CHAO, L., and CHAO, J. (1994). Identification of a major genetic locus linked sodium-sensitivity in genetically hypertensive rats. Hypertension 24, 387.
16. LOWRY, O.H., ROSEBROUGH, N.J., FARR, A.L., and RANDALL, R.J. (1951). Protein measurement with the folin phenol reagent. J. Biol. Chem. 193, 265-275.
17. MADEDDU, P., CHAO, J., CHAO, L., SOREGAROLI, M., VALCAMONICO, A., VALSECCHI, L., GLORIOSO, N., and FRUSCA, T. (1995). Urinary levels of kallikrein and kallistatin in pregnancy-induced hypertension. Hypertension in Pregnancy 14, 1-12.
18. MURRAY, S.R., CHAO, J., LIN, F-K., and CHAO, L. (1990). Kallikrein multigene families and the regulation of their expression. J. Cardiovasc. Pharmacol. 15(Suppl. 6), S7-S16.
19. WANG, C., CHAO, L., and CHAO, J. (1995). Direct gene delivery of human tissue kallikrein reduces blood pressure in spontaneously hypertensive rats. J. Clin. Invest. 95, 1710-1716.
20. YANG, T., TERADA, Y., NONOGUCHI, H., TSUJINO, M., TOMITA, K., and MARUMO, F. (1994). Distribution of kallikrein-binding protein mRNA in kidneys and difference between SHR and WKY rats. Am. J. Physiol. 267 (2 pt 2), F325-330.
21. ZHOU, G.X., CHAO, L., and CHAO, J. (1992). Kallistatin: A novel human tissue kallikrein inhibitor. Purification, characterization, and reactive center sequence. J. Biol. Chem. 267, 25873-25880.